BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21787232)

  • 1. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.
    Bish LT; Sleeper MM; Forbes SC; Morine KJ; Reynolds C; Singletary GE; Trafny D; Pham J; Bogan J; Kornegay JN; Vandenborne K; Walter GA; Sweeney HL
    Hum Gene Ther; 2011 Dec; 22(12):1499-509. PubMed ID: 21787232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
    Morine KJ; Bish LT; Pendrak K; Sleeper MM; Barton ER; Sweeney HL
    PLoS One; 2010 Feb; 5(2):e9176. PubMed ID: 20161803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.
    Nghiem PP; Hoffman EP; Mittal P; Brown KJ; Schatzberg SJ; Ghimbovschi S; Wang Z; Kornegay JN
    Am J Pathol; 2013 Nov; 183(5):1411-24. PubMed ID: 24160322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.
    Qiao C; Li J; Zheng H; Bogan J; Li J; Yuan Z; Zhang C; Bogan D; Kornegay J; Xiao X
    Hum Gene Ther; 2009 Jan; 20(1):1-10. PubMed ID: 18828709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
    Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
    Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype.
    Stoughton WB; Li J; Balog-Alvarez C; Kornegay JN
    Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.
    Robriquet F; Lardenois A; Babarit C; Larcher T; Dubreil L; Leroux I; Zuber C; Ledevin M; Deschamps JY; Fromes Y; Cherel Y; Guevel L; Rouger K
    PLoS One; 2015; 10(5):e0123336. PubMed ID: 25955839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
    Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M
    J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.
    Lardenois A; Jagot S; Lagarrigue M; Guével B; Ledevin M; Larcher T; Dubreil L; Pineau C; Rouger K; Guével L
    Proteomics; 2016 Jul; 16(14):2028-42. PubMed ID: 27246553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?
    Kerkis I; Ambrosio CE; Kerkis A; Martins DS; Zucconi E; Fonseca SA; Cabral RM; Maranduba CM; Gaiad TP; Morini AC; Vieira NM; Brolio MP; Sant'Anna OA; Miglino MA; Zatz M
    J Transl Med; 2008 Jul; 6():35. PubMed ID: 18598348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.